Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc
Johnson & Johnson Consumer Inc. announced today that it has entered into a definitive agreement to acquire NeoStrata Company, Inc., a global leader in...
Stryker completes acquisition of vertebral compression fracture portfolio from Becton, Dickinson and
Stryker Corp announced it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company)...
FDA Clearances the First 2D/3D Imaging-Guided Dedicated Prone Biopsy System of Hologic
Hologic, Inc announced the U.S. FDA clearance and commercial launch of the Affirm™ prone biopsy system, the first dedicated prone biopsy system to offer...
Johnson & Johnson Reports 2016 First-Quarter Results
Sales of $17.5 Billion Increased 0.6% Versus 2015 First QuarterFirst-Quarter EPS was $1.54Adjusted 2016 First-Quarter EPS of $1.68 increased 7.7%*Continued Strong Operational Sales GrowthExcluding...
naviHealth Inc to acquire Curaspan Health Group Inc
Company is a Leader in Discharge Planning and Care Transitions Technology for Hospitals, Health Systems and Post-Acute ProvidersCuraspan’s integrated workflow solution helps enable seamless...
Under-resourcing in Australian public hospitals has resulted in compromised care
IntroductionUnder-resourcing in Australian public hospitals has resulted in compromised care, with delayed diagnosis in surgery, inadequate treatment and psychological and social disruption related to...
C-Rad AB (CRAD B) – Financial and Strategic SWOT Analysis Review
C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets medical equipment for use in advanced radiation therapy. The company offers...
HumanOptics AG (H9O1) – Financial and Strategic SWOT Analysis Review
HumanOptics AG (HumanOptics) is a medical device company. The company develops, manufactures and sells eye implants. Its products include intraocular lenses, artificial iris, capsular...
iCo Therapeutics Announces First Quarter 2014 Financial Results
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented...
Biosensors Reports Financial Results for Fiscal Year 2014
Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its fourth fiscal quarter and fiscal...
